Over the 90-day window ending January 10, 2026, Resmed's three dominant insider ownership positions are held by Chairman And Ceo Michael J. Farrell (466.22K shares), President And Coo Robert Andrew Douglas (264.38K shares), Chief Administrative Officer David Pendarvis (89.73K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Michael J. Farrell | Chairman And Ceo | 466,223 | 08 Jan, 2026 |
| Robert Andrew Douglas | President And Coo | 264,375 | 20 Nov, 2023 |
| David Pendarvis | Chief Administrative Officer | 89,729 | 06 Jun, 2023 |
| Brett Sandercock | Chief Financial Officer | 86,495 | 05 Jan, 2026 |
| James Hollingshead | President And Sleep Business | 76,721 | 01 Dec, 2021 |
| Peter C Farrell | 66,773 | 08 Jan, 2026 | |
| Justin Leong | Chief Product Officer | 29,028 | 21 Nov, 2025 |
| Rajwant Sodhi | President And Saas Business | 26,731 | 02 Sep, 2021 |
| Ronald R Taylor | 24,771 | 21 Nov, 2025 | |
| Kaushik Ghoshal | Chief Commercial Officer And Saas | 19,353 | 11 Mar, 2025 |
| Richard Sulpizio | 17,796 | 21 Nov, 2024 | |
| Carol Burt | 17,048 | 24 Nov, 2025 | |
| Inc Resmed | 13,823 | 22 Nov, 2021 | |
| Harjit Gill | 10,940 | 24 Nov, 2025 | |
| Karen Drexler | 10,602 | 24 Nov, 2025 | |
| Lucile Blaise | President And Sleep & Rc Business | 10,305 | 15 Nov, 2023 |
| Michael J Rider | Global General Counsel | 9,741 | 05 Jan, 2026 |
| Desney Tan | 6,002 | 24 Nov, 2025 | |
| John Hernandez | 5,118 | 24 Nov, 2025 | |
| Witte Jan De | 4,261 | 26 Nov, 2025 | |
| Christopher Delorefice | 2,423 | 21 Nov, 2025 | |
| Nicole Mowad-Nassar | 777 | 24 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $248.83 | 66,773 | D | S |
| 07 Jan, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 07 Jan, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $248.46 | 466,223 | D | S |
| 02 Jan, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $241.75 | 86,495 | D | S |
| 02 Jan, 2026 | Michael J Rider | ResMed Common Stock | D | 50 | $241.75 | 9,741 | D | S |
| 08 Dec, 2025 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $251.41 | 466,223 | D | S |
| 08 Dec, 2025 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 03 Dec, 2025 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $251.47 | 68,773 | D | S |
| 01 Dec, 2025 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $244.16 | 87,495 | D | S |
| 01 Dec, 2025 | Michael J Rider | ResMed Common Stock | D | 50 | $244.16 | 9,791 | D | S |
| 25 Nov, 2025 | Witte Jan De | ReMed Common Stock | D | 2,055 | $255.00 | 4,261 | D | S |
| 20 Nov, 2025 | Ronald R Taylor | ResMed Common Stock | A | 1,073 | $0.00 | 24,771 | D | A |
| 20 Nov, 2025 | Peter C Farrell | ResMed Common Stock | A | 536 | $0.00 | 70,773 | D | A |
| 20 Nov, 2025 | Brett Sandercock | ResMed Common Stock | A | 2,710 | $0.00 | 88,495 | D | A |
| 20 Nov, 2025 | Michael J. Farrell | ResMed Common Stock | A | 13,551 | $0.00 | 473,520 | D | A |
| 20 Nov, 2025 | Michael J. Farrell | ResMed Common Stock | D | 7,297 | $0.00 | 466,223 | D | F |
| 20 Nov, 2025 | Carol Burt | ResMed Common Stock | A | 1,073 | $0.00 | 2,156 | D | A |
| 20 Nov, 2025 | Karen Drexler | ResMed Common Stock | A | 1,073 | $0.00 | 10,602 | D | A |
| 20 Nov, 2025 | Harjit Gill | ResMed Common Stock | A | 1,073 | $0.00 | 10,940 | D | A |
| 20 Nov, 2025 | Witte Jan De | ReMed Common Stock | A | 1,073 | $0.00 | 6,316 | D | A |